Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease

American Journal of Industrial Medicine

Volumn 52, Issue 10, 2009, Pages 762-773

  Mroz, Margaret M ^a   Maier, Lisa A ^a,b,c   Strand, Matthew ^a,c   Silviera, Lori ^a   Newman, Lee S ^b,c  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Food Science and Human Nutrition   (United States)

Author keywords

Beryllium; Chronic beryllium disease; Medical surveillance

Indexed keywords

BERYLLIUM; METHOTREXATE; PENTOXIFYLLINE; PREDNISONE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BERYLLIOSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GAS EXCHANGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FUNCTION TEST; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PERIODIC MEDICAL EXAMINATION; TOTAL LUNG CAPACITY; WORKPLACE; CELL PROLIFERATION; COMPARATIVE STUDY; DRUG EFFECTS; HEALTH SURVEY; LONGITUDINAL STUDY; LYMPHOCYTE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TOXICITY; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BERYLLIOSIS; BERYLLIUM; CELL PROLIFERATION; COLORADO; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONGITUDINAL STUDIES; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; POPULATION SURVEILLANCE; RESPIRATORY FUNCTION TESTS; UNITED STATES;

EID: 70349119985     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.20736     Document Type: Article

References (44)

1. Borak J, Woolf SH, Fields CA. 2006. Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: An evidence-based assessment. J Occup Environ Med 48:937. (Pubitemid 44394332)
2. Contini S, Mattioli G, Berretta F, Bergamaschi A, Sullotto F, Spigo A, Verniano P, Amicosante M. 2006. Berylliosis in Italy: A case of "sarcoidosis" under the threshold limit value. Med Lav 97:592.
3. Cullen MR, Cherniack MG, Kominsky JR. 1986. Chronic beryllium disease in the United States. Sem Respir Med 7:203.
4. Cullen MR, Kominsky JR, Rossman MD, Cherniack MG, Rankin JA, Balmes JR, Kern J, Daniele RP, Palmer L, Naegel GP, McManus K, Cruz. R. 1987. Chronic beryllium disease in a precious metal refinery: Clinical, epidemiologic, and immunologic evidence for continuing risk from exposure to low level beryllium fume. Am Rev Respir Dis 135:201.
5. Cummings KJ, Deubner DC, Day GA, Henneberger PK, Kitt MM, Kent MS, Kreiss K, Schuler CR. 2007. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers. Occup Environ Med 64:134. (Pubitemid 46256217)
6. DeNardi JM, Van Ordstrand HS, Carmody MG. 1949a. Acute dermatitis and pneumonitis in beryllium workers: Review of 406 cases in eight-year period with follow-up on recoveries. Ohio State Med J 45:567.
7. DeNardi JM, Van Ordstrand HS, Carmody MG. 1949b. Chronic pulmonary granulomatosis: Report of ten cases. Am J Med 7:345.
8. DOE, U.D.O.E. 1999. Chronic beryllium disease prevention program. Fed Regist 64:68854.
9. Eisenbud M, Lisson J. 1983. Epidemiological aspects of beryllium-induced non-malignant lung disease: A 30-year update. J Occup Med 25:196.
10. Fireman E, Haimsky E, Noiderfer M, Priel I, Lerman Y. 2003. Misdiagnosis of sarcoidosis in patients with chronic beryllium disease. Sarcoidosis Vasc Diffuse Lung Dis 20:144. (Pubitemid 36841696)
11. Gaensler EA, Verstraeten JM, Weil WB, Cugell DW, Marks A, Cadigan JB, Jones RH, Ellicott MF. 1959. Respiratory pathophysiology in chronic beryllium disease: Review of 30 cases with some observations after long term steroid therapy. AMA Arch Ind Health 19:132.
12. Hanifin JM, Epstein WL, Cline MJ. 1970. In vitro studies of granulomatous hypersensitivity to beryllium. J Invest Dermatol 55:284.
13. Hardy HL. 1950. Clinical and epidemilogic aspects. In: Vorwald AJ, editor. Pneumoconiosis. Sixth Saranac Symposium. New York: Paul B. Hoeber, Inc. p. 133.
14. Hardy HL. 1955. The disability found in persons exposed to certain beryllium compounds. AMA Arch Ind Health 12:174.
15. Hardy HL. 1965. Beryllium poisoning: Lessons in control of man-made disease. N Engl J Med 273:1188.
16. Hardy HL, Tabershaw IR. 1946. Delayed chemical pneumonitis in workers exposed to beryllium compounds. J Ind Hyg Toxicol 28:197.
17. Hardy H, Rabe EW, Lorch S. 1966. United States Beryllium Case Registry (1952-1966). J Occup Med 9:271.
18. Henneberger PK, Cumro D, Deubner DD, Kent MS, McCawley M, Kreiss K. 2001. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health 74:167. (Pubitemid 32377453)
19. International Labor Organization. 1980. Guidelines for the Use of ILO International Classification of Radiographs of Pneumoconioses. Geneva, Switzerland: International Labour Office.
20. Jonth AC, Silveira L, Fingerlin TE, Sato H, Luby JC, Welsh KI, Rose CS, Newman LS, du Bois RM, Maier LA, ACCESS Group. 2007. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. J Immunol 179(6):4255.
21. Kreiss K, Newman LS, Mroz MM, Campbell PA. 1989. Screening blood test identifies subclinical beryllium disease. J Occup Med 31:603. (Pubitemid 19179743)
22. Kreiss K, Wasserman S, Mroz MM, Newman LS. 1993a. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J Occup Med 35:267. (Pubitemid 23084157)
23. Kreiss K, Mroz MM, Zhen B, Martyny J, Newman LS. 1993b. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis 148:985. (Pubitemid 23301218)
24. Kreiss K, Mroz MM, Newman LS, Martyny J, Zhen B. 1996. Machining risk of beryllium disease and sensitization with median exposures below 2 mg/m3. Am J Ind Med 30:16. (Pubitemid 26279451)
25. Kreiss K, Mroz MM, Zhen B, Wiedemann H, Barna B. 1997. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med 54:605. (Pubitemid 27374989)
26. Lundgren RA, Maier LA, Rose CS, Balkissoon RC, Newman LS. 2001. Indirect and direct gas exchange at maximum exercise in beryllium sensitization and disease. Chest 120:1702.
27. Maier LA, Sawyer RT, Bauer RA, Kittle LA, Lympany P, McGrath D, Dubois R, Daniloff E, Rose CS, Newman LS. 2001. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease. Am J Respir Crit Care Med 164:1192. (Pubitemid 33052249)
28. Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman LS. 1991. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol 88:54.
29. Muller Quernheim J, Gaede KI, Fireman E, Zissel G. 2006. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 27:1190. (Pubitemid 44914303)
30. Newman LS, Kreiss K, King TE, Jr., Seay S, Campbell PA. 1989. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis 139:1479.
31. Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon R. 2001. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med 43:231. (Pubitemid 32238502)
32. Newman LS, Mroz MM, Balkissoon R, Maier LA. 2005. Beryllium sensitization progresses to chronic beryllium disease: A longitudinal study of disease risk. Am J Respir Crit Care Med 171:54. (Pubitemid 40051695)
33. Pappas GP, Newman LS. 1993. Early pulmonary physiologic abnormalities in beryllium disease. Am Rev Respir Dis 148:661.
34. Pott GB, Palmer BE, Sullivan AK, Silveira LJ, Maier LA, Newman LS, Fontenot AP. 2005. Frequency of beryllium-specific, Th1-Type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease. J Allergy Clin Immunol 115:1036.
35. Rom WN, Lockey JE, Bang. KM. 1983. Reversible beryllium sensitization in a prospective study of beryllium workers. Arch Environ Health 38:302.
36. Rosenman K, Hertzberg V, Rice C, Reilly MJ, Aronchick J, Parker JE, Regovich J, Rossman M. 2005. Chronic beryllium disease and sensitization at a beryllium processing facility. Environ Health Perspect 113:1366. (Pubitemid 41511994)
37. Rossman MD, Kern JA, Elias JA, Cullen MR, Epstein PE, Preuss OP, Markham TN, Daniele RP. 1988. Proliferative response of bronchoalveolar lymphocytes to beryllium: A test for chronic beryllium disease. Ann Intern Med 108:687.
38. SAS Institute, Inc. 1988. In SAS State User's Guide, Release 6.03. North Carolina: Cary.
39. Schuler CR, Kent MS, Deubner DC, Berakis MT, McCawley M, Henneberger PK, Rossman MD, Kreiss K. 2005. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med 47:195. (Pubitemid 40326251)
40. Sood A, Beckett WS, Cullen MR. 2004. Variable response to long-term corticosteroid therapy in chronic beryllium disease. Chest 126:2000. (Pubitemid 39644011)
41. Stange AW, Hilmas DE, Furman FJ, Gatliffe TR. 2001. Beryllium sensitization and chronic beryllium disease at a former nuclear weapons facility. Appl Occup Environ Hyg 16:405.
42. Stanton ML, Henneberger PK, Kent MS, Deubner DC, Kreiss K, Schuler CR. 2006. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers. J Occup Environ Med 48:204. (Pubitemid 43239594)
43. Welch L, Ringen K, Bingham E, Dement J, Takaro T, McGowan W, Chen A, Quinn P. 2004. Screening for beryllium disease among construction trade workers at department of energy nuclear sites. Am J Ind Med 46:207. (Pubitemid 39180816)
44. Williams WR, Jones Williams WJ. 1982. Development of beryllium lymphocyte transformation tests in chronic beryllium disease. Int Arch Allergy Appl Immunol 67:175.